L-Asparaginase (EC 3.5.1.1) inhibited respiration in sensitive, but not resistant, lines of mukine lymphoma 6C3HED. Glucose, in these tumor lines, was principally converted to lactate, and very little was oxidized in the citric acid cycle or hexose monophosphate shunt. The oncolytic effects of L-asparaginase (L-asparagine aminohydrolase; EC 3.5.1.1) have been ascribed to the deamination of asparagine, leading to depletion of intracellular asparagine in tumor cells that lack asparagine synthetase (1, 2). The resulting deficiency is ultimately seen as a general reduction of macromolecular syntheses (3-6). However, asparaginase has diverse effects that may not be completely explained on this basis: cells lacking asparagine synthetase, when cultured in asparagine-deficient tissue culture media, show a marked delay in proliferation, but do not die (7); asparaginase inhibits lectin-induced blast transformation of lymphocytes, and addition of exogenous asparagine does not prevent this effect (5, 8); asparaginase has immunosuppressive properties that are not consistently reversed by asparagine (4, 5); tumor cells in culture show marked cytotoxic changes within an hour of exposure to asparaginase (9), and it seems unlikely that deprivation of asparagine alone would have such a rapid effect on cell structure; asparaginase delays mitotic events in regenerating rat liver, a tissue in which asparagine synthetase deficiency has not been demonstrated (10).Inhibition of blast transformation by asparaginase and its immunosuppressive property suggest an effect of the enzyme on the cell surface. The production of energy may also be affected, since a number of tumors and cell lines derive much of their respiratory energy from glutamine and glutamate (11-13). Aspartate and asparagine are also linked to the citric acid cycle, and this adds another argument for complexity. Asparaginase, by depleting asparagine with a resulting increase in aspartate levels, might lead to accumulation of oxalo- Studies with Isotopes. Cell suspensions were incubated with labeled substrates (New England Nuclear Corp.) at 370 for 45 min in sealed, 25-ml Erlenmeyer flasks equipped with disposable tubes in center wells. Ten minutes before the end of incubation, 0.5 ml of hyamine hydroxide, a CO2 absorbant, was injected into the center-well tubes. After incubation, flasks were put into an ice-bath to stop metabolic activity.CO2 absorption was allowed to continue for an additional 30 min. The center-well tubes, containing hyamine, were then placed directly into liquid scintillation counting vials containing 15 ml of 0.4% 2,5-diphenyloxazole (PPO) and 0.1% 1,